Oral acyclovir in prevention of herpes labialis: A randomized, double-blind, multi-centered clinical trial

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 85, Issue 1, 1998, Pages 55-59

  Raborn, G W ^a   Martel, Alain Y ^b   Grace, Michael G A ^a   McGaw, W T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT;

ADULT; ARTICLE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; FEMALE; HERPES LABIALIS; HUMAN; MALE; MULTICENTER STUDY; NONPARAMETRIC TEST; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; HERPES LABIALIS; HUMANS; MALE; RECURRENCE; STATISTICS, NONPARAMETRIC;

EID: 0031606818     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(98)90398-5     Document Type: Article

References (18)

1. Elion GB. The biochemistry and mechanism of action of acyclovir. J Antimicrob Chemother 1983;12(suppl B):9-17.
2. Collins P. The spectrum of antiviral activities of acyclovir in vitro and vivo. J Antomicro Chemother 1983;12(suppl B): 19-27.
3. Baker DA, editor. Acyclovir therapy for herpes virus infections. New York: Marcel Dekker; 1990.
4. Spruance SL, Schnipper LE, Overall JC, Kern ER, Wester B, Modlin J, et al. Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J Infect Dis 1982:146:85-90.
5. Spruance SL, Crumpacker CS, Schnipper LE, Kern ER, Marlowe S, Arndt KA, Overall JC. Early patient initiated treatment of herpes labialis with topical 10% acyclovir. Antimicrob Agents Chemother 1984;25:553-5.
6. Raborn GW, McGaw WT, Grace MGA, Houle L. Herpes Labialis treatment with 5% acyclovir ointment: a double-blind, randomized, placebo-controlled trial. J Can Dent Assoc 1998;55:135-7.
7. Raborn GW, McGaw WT, Grace MGA, Percy J, Samuels S. Herpes Labialis treatment with acyclovir 5% modified aqueous cream: a double-blind, randomized trial. Oral Surg Oral Med Oral Path 1989;67:676-9.
8. Raborn GW, McGaw WT, Grace MGA, Tyrrell LD, Samuels SM. Oral acyclovir and herpes labials: a randomized, doubleblind, placebo-controlled study. JADA 1987;115:38-42.
9. Spruance SL, Hammit ML, Hoge WS, Davis G, Mills J. Acyclovir prevents reactivation of herpes liabials in skiers. JAMA 1988;260:1597-9.
10. Fiddian AP, Yeo JM, Stubbings R, Dean D. Successful treatment of herpes labialis with topical acyclovir. Br Med J 1983;286:1699-701.
11. Gibson JR, Klaber MR, Harvey SG, Tosti A, Jones D, Yeo JM. Prophylaxis against herpes labialis with acyclovir cream: a placebo controlled study. Dermatologica 1986;172:104-7.
12. Shaw M, King M, Best JM, Banatvala JE, Gibson JR. Failure of acyclovir cream in treatment of recurrent herpes labialis. Br Med J 1985;291:7-9.
13. Rooney JF, Manni ML, Dumois J, Wohlenberg CR, Aling D, Straus SE, et al. Suppression of frequently recurrent herpes liabialis by daily oral acyclovir. Clinical Research 1992;40:319A
14. Straus SE, Tabiff HE, Seidlin M, Bachrach S, Linijger L, Di Giovanna JJ, et al. Suppression of frequently recurring genital herpes: a placebo-controlled double-blind trial of oral acyclovir. NEJM 1984;310:1545-50.
15. Kaplowitz LG, Baker D, Gelb L, Blythe J, Hale R, Frost P, et al. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. JAMA 1991;265:747-51.
16. Spruance SL. Herpes simplex labialis in clinical management of herpes viruses, In: Sacks SL, Straus SE, Whitley RJ, Griffiths PD, editors. Clinical management of herpes viruses. Washington: IOS; 1995. p. 6-7.
17. De Miranda P, Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother 1983;12:29-37.
18. Freeman DJ, Sheth NV, Spruance SL. Failure of topical acyclovir (ACV) in ointment to penetrate human skin. Antimicrob Agents Chemother 1986;29:730-2.